Cargando…

Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16.

Detalles Bibliográficos
Autores principales:	Smith, M. A., Merry, S., Smith, J. G., Kaye, S. B.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1988
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246452/ https://www.ncbi.nlm.nih.gov/pubmed/3408645

Ejemplares similares

Infusion-rate independent cellular adriamycin concentrations and cytotoxicity to human bone marrow clonogenic cells (CFU-GM).
por: Raijmakers, R., et al.
Publicado: (1987)

The effect of etoposide on human CFU-GM.
por: Bailey-Wood, R., et al.
Publicado: (1985)

Inherent adriamycin resistance in a murine tumour line: circumvention with verapamil and norverapamil.
por: Merry, S., et al.
Publicado: (1989)

Resistance of human glioma to adriamycin in vitro: the role of membrane transport and its circumvention with verapamil.
por: Merry, S., et al.
Publicado: (1986)

Proceedings: Identification of hypoxic mouse bone marrow CFU in vivo.
por: Keizer, H. J., et al.
Publicado: (1975)

The sensitivity to hyperthermia of human granulocyte/macrophage progenitor cells (CFU-GM) derived from blood or marrow of normal subjects and patients with chronic granulocytic leukaemia.
por: Blackburn, M. J., et al.
Publicado: (1984)

Chemosensitization to adriamycin by cyclosporin A and verapamil in human retinoblastoma cell lines.
por: Lee, T. W., et al.
Publicado: (1993)

Detection of Adriamycin–DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations
por: Coldwell, Kate E., et al.
Publicado: (2008)

Reduction of CFU-GM and circulating hematopoietic progenitors in a subgroup of children with chronic neutropenia associated with severe infections and delayed recovery
por: Timeus, Fabio, et al.
Publicado: (2019)

Modification of adriamycin-induced cytotoxicity by recombinant human interferon-gamma and/or verapamil in human stomach cancer cells.
por: Hong, W. S., et al.
Publicado: (1992)

Circumvention of drug resistance in human non-small cell lung cancer in vitro by verapamil.
por: Merry, S., et al.
Publicado: (1987)

Isolation and characterization of the erythroid progenitor cell: CFU-E
Publicado: (1983)

Colony-forming unit cell (CFU-C) assays at diagnosis: CFU-G/M cluster predicts overall survival in myelodysplastic syndrome patients independently of IPSS-R
por: Li, Bing, et al.
Publicado: (2016)

Upregulation of Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Mediates the Reversal Effect of Verapamil on Chemo-Resistance to Adriamycin of Hepatocellular Carcinoma
por: Yang, Guangshan, et al.
Publicado: (2018)

117 Allocation of Therapist Time: Mobilization of CFU’s in Hand w/Burn Injury
por: Fletchall, Sandra, et al.
Publicado: (2023)

Verapamil in Diabetes
por: Poudel, Resham Raj, et al.
Publicado: (2017)

Verapamil potentiation of melphalan cytotoxicity and cellular uptake in murine fibrosarcoma and bone marrow.
por: Robinson, B. A., et al.
Publicado: (1985)

Effects of Methylxanthine Derivatives on Adriamycin Concentration and Antitumor Activity
por: Sadzuka, Yasuyuki, et al.
Publicado: (1995)

Phase I and pharmacokinetic study of D-verapamil and doxorubicin.
por: Bissett, D., et al.
Publicado: (1991)

P794: DIFFERENTIATION POTENTIAL AND RELATIVE GENE EXPRESSION LEVELS ARE CHANGED IN CFU-F FROM BONE MARROW OF APLASTIC ANEMIA PATIENTS AT THE ONSET OF THE DISEASE
por: Dorofeeva, A., et al.
Publicado: (2022)

Study of CFU for individual microorganisms in mixed cultures with a known ratio using MBRT
por: Nandy, Subir Kumar, et al.
Publicado: (2014)

Effects of CreER(T2), 4-OH Tamoxifen, and Gender on CFU-F Assays
por: McHaffie, Sophie L., et al.
Publicado: (2016)

Spot Assay and Colony Forming Unit (CFU) Analyses–based sensitivity test for Candida albicans and Saccharomyces cerevisiae
por: Sahu, Satya Ranjan, et al.
Publicado: (2023)

The Role of VP16 in the Life Cycle of Alphaherpesviruses
por: Fan, Dengjian, et al.
Publicado: (2020)

Host factors associated with either VP16 or VP16‐induced complex differentially affect HSV‐1 lytic infection
por: Ding, Xiuyan, et al.
Publicado: (2022)

A comparison of the response to hyperthermia of murine haemopoietic stem cells (CFU-S) and L1210 leukaemia cells: enhanced killing of leukaemic cells in presence of normal marrow cells.
por: Symonds, R. P., et al.
Publicado: (1981)

The Relevance and Added Value of Geriatric Medicine (GM): Introducing GM to Non-Geriatricians
por: Kotsani, Marina, et al.
Publicado: (2021)

Adriamycin-resistant cells are significantly less fit than adriamycin-sensitive cells in cervical cancer
por: Qi, Min, et al.
Publicado: (2021)

Counting Mycobacteria in Infected Human Cells and Mouse Tissue: A Comparison between qPCR and CFU
por: Pathak, Sharad, et al.
Publicado: (2012)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Effect of adriamycin on CFUGM at plasma concentrations found following therapeutic infusions.
por: Bailey-Wood, R., et al.
Publicado: (1984)

Structure of the VP16 Transactivator Target in ARC/Mediator
por: Milbradt, Alexander G., et al.
Publicado: (2011)

Characterisation of VP-16-induced DNA cleavage in oestrogen-stimulated human breast cancer cells.
por: Epstein, R. J., et al.
Publicado: (1988)

Verapamil potentiation of doxorubicin resistance development in B16 melanoma cells both in vitro and in vivo.
por: Formelli, F., et al.
Publicado: (1988)

OpenCFU, a New Free and Open-Source Software to Count Cell Colonies and Other Circular Objects
por: Geissmann, Quentin
Publicado: (2013)

The Assessment of Parameters Affecting the Quality of Cord Blood by the Appliance of the Annexin V Staining Method and Correlation with CFU Assays
por: Radke, Teja Falk, et al.
Publicado: (2013)

Bovine Herpesvirus 1 U(L)49.5 Interacts with gM and VP22 To Ensure Virus Cell-to-Cell Spread and Virion Incorporation: Novel Role for VP22 in gM-Independent U(L)49.5 Virion Incorporation
por: Pannhorst, Katrin, et al.
Publicado: (2018)

Antitumour activity and pharmacokinetics of niosome encapsulated adriamycin in monolayer, spheroid and xenograft.
por: Kerr, D. J., et al.
Publicado: (1988)

Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo.
por: Klugmann, F. B., et al.
Publicado: (1986)

Crystallization and preliminary crystallographic analysis of the major capsid proteins VP16 and VP17 of bacteriophage P23-77
por: Rissanen, Ilona, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_03fpfm9n477bioucl0iqlig71p